| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,902 |
21,125 |
$1.41M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,563 |
14,880 |
$1.17M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,295 |
6,142 |
$517K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
887 |
859 |
$59K |
| 99215 |
Prolong outpt/office vis |
585 |
560 |
$53K |
| 87631 |
|
374 |
362 |
$14K |
| 99205 |
Prolong outpt/office vis |
124 |
120 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,328 |
1,796 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
255 |
238 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
332 |
298 |
$9K |
| 99000 |
|
2,499 |
2,393 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,366 |
1,205 |
$6K |
| 36410 |
|
409 |
393 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
306 |
267 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
103 |
102 |
$4K |
| 97597 |
|
72 |
56 |
$4K |
| 81025 |
|
540 |
510 |
$2K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
26,435 |
20,291 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
66 |
$1K |
| 83014 |
|
367 |
352 |
$1K |
| 81003 |
|
1,014 |
984 |
$944.82 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
174 |
151 |
$929.13 |
| 93000 |
|
122 |
119 |
$705.51 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$563.14 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
93 |
90 |
$530.42 |
| 99051 |
|
55 |
50 |
$501.15 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
27 |
$485.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
985 |
922 |
$361.21 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12 |
12 |
$348.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
814 |
749 |
$242.71 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
30 |
$196.55 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
127 |
109 |
$194.87 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
96 |
90 |
$186.18 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
45 |
19 |
$149.78 |
| 71046 |
Radiologic examination, chest; 2 views |
18 |
14 |
$148.77 |
| 90630 |
|
19 |
14 |
$36.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
32 |
30 |
$3.23 |
| 36415 |
Collection of venous blood by venipuncture |
2,188 |
2,103 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18 |
14 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
18 |
14 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.00 |